<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30010628</article-id>
<article-id pub-id-type="pmc">6063497</article-id>
<article-id pub-id-type="publisher-id">122203</article-id>
<article-id pub-id-type="doi">10.1172/JCI122203</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Accelerating the reversal of inflammatory pain with NPD1 and its receptor GPR37</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Lintao</given-names>
</name>
<email>lqu4@jhmi.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Caterina</surname>
<given-names>Michael J.</given-names>
</name>
<email>caterina@jhmi.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurosurgery,</aff>
<aff id="A2"><label>2</label>Neurosurgery Pain Research Institute,</aff>
<aff id="A3"><label>3</label>Department of Biological Chemistry, and</aff>
<aff id="A4"><label>4</label>Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Michael J. Caterina, 725 North Wolfe Street, Baltimore, Maryland 21205, USA. Phone: 410.502.5457; Email: <email>caterina@jhmi.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2018-07-16T16:00:00-0400" publication-format="electronic">
<day>16</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2018-08-01T16:00:00-0400" publication-format="print">
<day>1</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>8</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>128</volume>
<issue>8</issue>
<fpage>3246</fpage>
<lpage>3249</lpage>
<permissions>
<copyright-statement>Copyright © 2018, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/122203">This article is available online at https://www.jci.org/articles/view/122203</self-uri>
<abstract>
<p>Resolution of inflammation is a critical process that is facilitated by specialized proresolving mediators (SPMs). In this issue, Bang et al. show that the G protein–coupled receptor GPR37 is a receptor for one such SPM, neuroprotectin D1. They also show that GPR37 activation in macrophages enhances phagocytosis, shifts cytokine release toward an antiinflammatory profile, and thereby helps to reverse inflammatory pain.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>